Wallach added, “We share CU Anschutz’s vision to simultaneously fuel medical innovation while reducing the time required to get those innovations where they are needed most – to the patient. Our father believed that to move the needle, it’s important to invest in places that aren’t constrained by convention and are led and staffed by those driven to enhance the quality of life for those in our community and beyond.
Much of the $200 million will be used to add faculty, researchers and support staff to the new institute. It’s anticipated that additional funding will come from both federal research grants and private biotechnology businesses that will develop the institute’s research discoveries into new therapies and products.
According to the university, the institute will also be involved in manufacturing, delivery and implementation of new therapies, as well as providing the regulatory infrastructure and investments necessary for commercializing novel therapies for patients. "The Gates Institute will make it possible for our faculty to achieve the vast potential of cell and gene therapies,” said John J. Reilly Jr., MD, dean of theand vice chancellor for health affairs at CU Anschutz. “With previous support, we have recruited talented faculty and staff, and we have invested in state-of-the-art equipment.
“I’m looking forward to advancing the important work started at the Gates Center as we evolve into an institute focused on regenerative, cell and gene therapies. This is an incredible opportunity to help patients facing serious health issues and will change the face of medicine as we know it,” said Fry.The UC Anschutz Medical Campus is located in Aurora, Colorado, a site that was developed with the help of more than $90 million in donations from the Anschutz Foundation.